Michael F. DeMane - 30 Jun 2023 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael F. DeMane
Issuer symbol
N/A
Transactions as of
30 Jun 2023
Net transactions value
$0
Form type
4
Filing time
05 Jul 2023, 17:10:10 UTC
Previous filing
09 Jun 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +1,032 +3.7% $0.000000 28,804 30 Jun 2023 Direct F1, F2
holding NVRO Common Stock 164,344 30 Jun 2023 See footnote F3
holding NVRO Common Stock 122,541 30 Jun 2023 See footnote F4
holding NVRO Common Stock 131,225 30 Jun 2023 See footnote F5
holding NVRO Common Stock 18,266 30 Jun 2023 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
F2 Includes 6,754 restricted stock units.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.